Combo Equal Screen
Filter for large-cap, quality, and low-leverage holdings, rank by composite quality/value/size score, keep the top 20 names, and equal-weight the selected names.
AI Summary
Highly concentrated equal-weight health care screen with improved absolute returns, but weak benchmark-relative efficiency and sizable drawdown risk.
Portfolio Snapshot
Current optimized weights for the selected default session.
| Symbol | Name | Sector | Weight | Diff |
|---|---|---|---|---|
| ISRG | Intuitive Surgical, Inc. | Health Care | 16.67% | +13.57 |
| VRTX | Vertex Pharmaceuticals Incorporated | Health Care | 16.67% | +14.55 |
| INCY | Incyte Corporation | Health Care | 16.67% | +16.35 |
| ALGN | Align Technology, Inc. | Health Care | 16.67% | +16.45 |
| WST | West Pharmaceutical Services, Inc. | Health Care | 16.67% | +16.21 |
| RMD | ResMed Inc. | Health Care | 16.67% | +16.08 |
Sector Exposure
- Health Care100.02%
Weight Changes
Notable position adjustments in the latest snapshot.
- ISRGIntuitive Surgical, Inc.16.67% (+13.57)
- VRTXVertex Pharmaceuticals Incorporated16.67% (+14.55)
- INCYIncyte Corporation16.67% (+16.35)
- ALGNAlign Technology, Inc.16.67% (+16.45)
- WSTWest Pharmaceutical Services, Inc.16.67% (+16.21)
- RMDResMed Inc.16.67% (+16.08)
Performance vs Benchmark
Strategy NAV vs benchmark — hover for exact values.
Alpha Trend
Excess return vs benchmark over time.
Drawdown Trend
Underwater curve and peak drawdown marker.
Turnover Trend
Per-period turnover with average reference.
Strategy Comparison
All four default strategies side-by-side.
| Strategy | Annualized | Alpha | Sharpe | Max DD |
|---|---|---|---|---|
| Baseline | 8.14% | -1.49% | 0.56 | -28.55% |
| Momentum Screen | 5.74% | -3.21% | 0.40 | -26.41% |
| Basic Value Screen | 6.92% | -2.01% | 0.45 | -38.07% |
| Combo Equal Screen | 10.42% | -1.06% | 0.58 | -30.54% |
vs Baseline: Annualized +2.28 · Alpha +0.43 · Sharpe +0.03
Recent Periods
Per-period performance vs benchmark.
| Period | Strategy | Benchmark | Excess | Turnover | Trades |
|---|---|---|---|---|---|
| 2025-05-31 | 2.13% | 3.75% | -1.62 | 6.11 | 8 |
| 2025-06-30 | 4.87% | 2.69% | +2.18 | 22.23 | 9 |
| 2025-07-31 | 1.90% | 2.05% | -0.15 | 16.46 | 9 |
| 2025-08-31 | -2.07% | 3.66% | -5.73 | 23.37 | 9 |
| 2025-09-30 | 6.10% | 2.05% | +4.05 | 42.18 | 9 |
| 2025-10-31 | 6.68% | 0.20% | +6.48 | 7.37 | 7 |
| 2025-11-30 | 0.66% | 0.99% | -0.33 | 5.56 | 7 |
| 2025-12-31 | -1.71% | 1.47% | -3.19 | 56.61 | 8 |
| 2026-01-31 | 4.86% | -1.35% | +6.21 | 8.22 | 6 |
| 2026-02-28 | -9.40% | -7.93% | -1.48 | 5.02 | 6 |
| 2026-03-31 | 2.49% | 9.42% | -6.93 | 2.81 | 6 |
| 2026-04-30 | -0.42% | 4.11% | -4.52 | 7.01 | 6 |
Strategy Q&A
Pre-generated questions and answers about this strategy.
- combo13FChat AI
How did the combo equal-weight screen change portfolio structure versus the baseline?
Combo Equal Screen changes structure by selecting ISRG (Intuitive Surgical, Inc.) 16.67%, VRTX (Vertex Pharmaceuticals Incorporated) 16.67%, INCY (Incyte Corporation) 16.67%, ALGN (Align Technology, Inc.) 16.67%, WST (West Pharmaceutical Services, Inc.) 16.67%, and RMD (ResMed Inc.) 16.67%. That produces top 5 83.35%, top 10 100.02%, top 20 100.02% and sector exposure of Health Care 100.02%. Compared with baseline concentration of top 5 43.85%, top 10 59.80%, top 20 80.01%, this is less about copying original sizing and more about testing a cleaner rules-based basket.
strategyViews.combo-equal-screen.topHoldingsstrategyViews.combo-equal-screen.concentration↳ Compare combo weights with Baseline weights and identify the largest reallocations.
- combo13FChat AI
Was the combo screen's result driven more by stock selection or by weight redistribution?
The combo result appears to be a mix of stock selection and weight redistribution. It selected ISRG (Intuitive Surgical, Inc.) 16.67%, VRTX (Vertex Pharmaceuticals Incorporated) 16.67%, INCY (Incyte Corporation) 16.67%, ALGN (Align Technology, Inc.) 16.67%, WST (West Pharmaceutical Services, Inc.) 16.67%, and RMD (ResMed Inc.) 16.67% and delivered return 10.42%, alpha -1.06%, beta 0.89, Sharpe 0.58, Sortino 0.81, and max drawdown -30.54%. Versus baseline, annualized return changed by 2.28%, alpha changed by 0.43%, Sharpe changed by 0.03, Sortino changed by 0.07, drawdown worsened by 1.99%. The selected-name list and changed weights are the first places to check whether performance came from better stocks or simply different sizing.
strategyViews.combo-equal-screen.topHoldingsstrategyViews.combo-equal-screen.metrics↳ Separate the combo result into selected names, weight changes, and return contribution.
- combo13FChat AI
Which names and sector exposures are driving the combo result?
The combo basket is led by ISRG (Intuitive Surgical, Inc.) 16.67%, VRTX (Vertex Pharmaceuticals Incorporated) 16.67%, INCY (Incyte Corporation) 16.67%, ALGN (Align Technology, Inc.) 16.67%, and WST (West Pharmaceutical Services, Inc.) 16.67%, with sector exposure of Health Care 100.02%. The latest change list shows ALGN increase to 16.67%; INCY increase to 16.67%; WST increase to 16.67%, so the user should inspect whether these are desirable active bets or just mechanical consequences of the screen.
strategyViews.combo-equal-screen.topHoldingsstrategyViews.combo-equal-screen.latestChanges↳ Review the combo basket's top sector bets, increased names, and reduced baseline names.
Other strategies for this fund
Baseline
Track disclosed holdings with the standard reporting lag and no active reweighting.
Momentum Screen
Select holdings by historically observable momentum, targeting roughly one quarter of each period's original member count and no more than 20 names; when a period has over 100 members, pre-rank to the top 50 first.
Basic Value Screen
Select holdings using PE, PB, P/FCF, and EV/EBITDA, targeting roughly one quarter of each period's original member count and no more than 20 names; when a period has over 100 members, pre-rank to the top 50 first.